{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:07:35Z","timestamp":1775646455017,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:00:00Z","timestamp":1536364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:00:00Z","timestamp":1536364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gen. Psychiatry"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperprolactinaemia is a common adverse effect of antipsychotics (APs). The results of Peony\u2010Glycyrrhiza decoction (PGD) as a potentially useful adjunctive treatment for hyperprolactinaemia are inconsistent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This meta\u2010analysis of randomised controlled trials (RCTs) examined the efficacy and safety of adjunctive PGD therapy for AP\u2010induced hyperprolactinaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      English (PubMed, Embase, Cochrane Library, PsycINFO) and Chinese (Chinese National Knowledge Infrastructure, Wanfang Data) databases were systematically searched up to 10\u00a0June 2018. The inclusion criteria were based on PICOS\u2014\n                      <jats:italic>P<\/jats:italic>\n                      articipants: adult patients with schizophrenia;\n                      <jats:italic>I<\/jats:italic>\n                      ntervention: PGD plus APs;\n                      <jats:italic>C<\/jats:italic>\n                      omparison: APs plus placebo or AP monotherapy;\n                      <jats:italic>O<\/jats:italic>\n                      utcomes: efficacy and safety;\n                      <jats:italic>S<\/jats:italic>\n                      tudy design: RCTs. The weighted mean difference (WMD) and risk ratio (RR) along with their 95% CIs were calculated using Review Manager (RevMan) V.5.3 software.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five RCTs (n=450) were included and analysed. Two RCTs (n=140) were double\u2010blind and four RCTs (n=409) reported \u2018random\u2019 assignment with specific description. The PGD group showed a significantly lower serum prolactin level at endpoint than the control group (n=380, WMD: \u221232.69 \u2009ng\/mL (95% \u2009CI \u221241.66 to 23.72),\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.00001,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      =97%). Similarly, the superiority of PGD over the control groups was also found in the improvement of hyperprolactinaemia\u2010related symptoms. No difference was found in the improvement of psychiatric symptoms assessed by the Positive and Negative Syndrome Scale (n=403, WMD: \u22120.62 (95% CI \u22122.38 to 1.15),\n                      <jats:italic>p<\/jats:italic>\n                      =0.49,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      =0%). There were similar rates of all\u2010cause discontinuation (n=330, RR 0.93 (95% CI 0.63 to 1.37),\n                      <jats:italic>p<\/jats:italic>\n                      =0.71,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      =0%) and adverse drug reactions between the two groups. According to the Grading of Recommendations Assessment, Development and Evaluation approach, the level of evidence of primary and secondary outcomes ranged from \u2018very low\u2019 (14.3%), \u2018low\u2019 (42.8%), \u2018moderate\u2019 (14.3%), to \u2018high\u2019 (28.6%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Current evidence supports the adjunctive use of PGD to suppress elevated prolactin and improve prolactin\u2010induced symptoms without significant adverse events in adult patients with AP\u2010induced hyperprolactinaemia. High\u2010quality RCTs with longer duration are needed to confirm these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>42016037017.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gpsych-2018-100003","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T10:35:22Z","timestamp":1538476522000},"update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Adjunctive Peony\u2010Glycyrrhiza decoction for antipsychotic\u2010induced hyperprolactinaemia: a meta\u2010analysis of randomised controlled trials"],"prefix":"10.1002","volume":"31","author":[{"given":"Wei","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Psychiatry The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital) Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong\u2010Bin","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurology Shenzhen Traditional Chinese Medicine Hospital Shenzhen China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai\u2010Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Psychiatry The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital) Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Jie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital) Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee H","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Melbourne Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor S","family":"Ungvari","sequence":"additional","affiliation":[{"name":"The University of Notre Dame Australia Fremantle Australia"},{"name":"Division of Psychiatry Medical School University of Western Australia Perth Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan\u2010Shan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Mental Health Center of Hebei Province Baoding China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan\u2010Ming","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Chongqing Jiangbei Mental Health Hospital Chongqing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao\u2010Min","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Suzhou Psychiatric Hospital The Affiliated Guangji Hospital of Soochow University Suzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Ping","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Psychiatry The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital) Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Tao","family":"Xiang","sequence":"additional","affiliation":[{"name":"Unit of Psychiatry Faculty of Health Sciences University of Macau Macau China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318172473c"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2015.08.024"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2012.683523"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216307087148"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291175"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1024a"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e31815ac4e5"},{"key":"e_1_2_12_9_2","first-page":"851","article-title":"Management of psychotropic\u2010induced hyperprolactinemia","volume":"11","author":"Marken PA","year":"1992","journal-title":"Clin Pharm"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.01.031"},{"key":"e_1_2_12_11_2","first-page":"CD006617","article-title":"Aripiprazole versus typical antipsychotic drugs for schizophrenia","volume":"3","author":"Bhattacharjee J","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05154yel"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070179"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09030358"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1010"},{"issue":"18","key":"e_1_2_12_16_2","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double\u2010blind study","volume":"65","author":"McQuade RD","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_12_17_2","first-page":"35","article-title":"Effects of peony licorice bolus of risperidone with different proportions on female schizophrenia patients suffered hyperprolactinemia [In Chinese]","volume":"32","author":"XIE SS","year":"2015","journal-title":"Medical Research and Education"},{"key":"e_1_2_12_18_2","first-page":"1471","article-title":"The efficacy and safety of shaoyao gancao decoction for treating antipsychotic\u2010induced hyperprolactinemia [In Chinese]","volume":"22","author":"DUAN D","year":"2011","journal-title":"Lishizhen Medicine and Materia Medica Research"},{"key":"e_1_2_12_19_2","first-page":"20\u20101","article-title":"Clinical study on shaoyao gancao decoction for treating risperidone\u2010induced hyperprolactinemia [In Chinese]","volume":"10","author":"XIANG XM","year":"2013","journal-title":"Medical Innovation of China"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.1996.tb00578.x"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199706000-00025"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000426177.36207.da"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00018"},{"key":"e_1_2_12_24_2","first-page":"1456","article-title":"Treatment of olanzapine\u2010induced hyperprolactinemia by Shaoyao Gancao Decoction [In Chinese]","volume":"36","author":"GU P","year":"2016","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000607"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7901670"},{"key":"e_1_2_12_27_2","volume-title":"The effection of Shaoyao Gancao Decoction in treating hyperprolactinemia caused by antipsychotics and cognitive function [In Chinese] [D","author":"YUE LF","year":"2016"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"e_1_2_12_30_2","volume-title":"ECDEU assessment manual for psychopharmacology (Revised) [M]","author":"GUY W","year":"1976"},{"key":"e_1_2_12_31_2","unstructured":"HIGGINSJ GreenS.2011.Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration.www.cochrane\u2010handbook.org."},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300060517716783"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20387"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_2_12_38_2","first-page":"3947","article-title":"A comparative study of shaoyao gancao decoction and Guifu Dihuang pill in the treatment of risperidone induced hyperprolactinemia [In Chinese]","volume":"5","author":"PAN YY","year":"2016","journal-title":"Modern Journal of integrated traditional Chinese and Western Medicine"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000312"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.3923\/ijp.2010.691.695"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.07.005"},{"key":"e_1_2_12_43_2","volume-title":"The Research of the Treatment for Mastopathia by Liver\u2010Spleen\u2010Harmonizing Therapy of Jinkui Yaolue\u2014Experimental Study on Effect of Dangguishaoyao Modified Decoction on LH,FSH,PRL and Histomorphology in Rats [D","author":"Chen FY","year":"2008"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.062653"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117699630"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"}],"container-title":["General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1136\/gpsych-2018-100003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1136\/gpsych-2018-100003","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1136\/gpsych-2018-100003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:33:42Z","timestamp":1775644422000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1136\/gpsych-2018-100003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1136\/gpsych-2018-100003"],"URL":"https:\/\/doi.org\/10.1136\/gpsych-2018-100003","archive":["Portico"],"relation":{},"ISSN":["2096-5923","2517-729X"],"issn-type":[{"value":"2096-5923","type":"print"},{"value":"2517-729X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,8]]},"article-number":"e100003"}}